Hepatitis C virus genotypes in Tirana, Albania

International Journal of Infectious Diseases

Volumn 18, Issue 1, 2014, Pages 90-93

  Haldeda, Migena ^a   Baume, Julien ^b   Tamalet, Catherine ^b,c   Bizhga, Melpomeni ^a   Colson, Philippe ^b,c  

^a UNIVERSITY HOSPITAL CENTER MOTHER TERESA   (Albania)

^b TIMONE HOSPITAL   (France)

^c AIX MARSEILLE UNIVERSITÉ   (France)

Author keywords

Albania; HCV epidemiology; HCV genotype; HCV NS3 protease; Hepatitis C

Indexed keywords

NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 5B; VIRUS RNA;

5' UNTRANSLATED REGION; ALBANIA; ANTIVIRAL RESISTANCE; ARTICLE; BLOOD SAMPLING; FEMALE; GENE SEQUENCE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; TREATMENT DURATION;

ALBANIA; HCV EPIDEMIOLOGY; HCV GENOTYPE; HCV NS3 PROTEASE; HEPATITIS C;

5' UNTRANSLATED REGIONS; ALBANIA; AMINO ACID SUBSTITUTION; ANTIVIRAL AGENTS; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; PROTEASE INHIBITORS; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84891530765     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2013.08.015     Document Type: Article

References (11)

1. Kamili S., Drobeniuc J., Araujo A.C., Hayden T.M. Laboratory diagnostics for hepatitis C virus infection. Clin Infect Dis 2012, 55(Suppl 1):S43-S48.
2. Colson P., Bregigeon S., Tourres C., Solas C., Poizot-Martin I., Tamalet C. Relapse of hepatitis C virus after 14 months of sustained virological response following pegylated-interferon alpha plus ribavirin therapy in a human immunodeficiency virus type 1 infected patient. J Clin Virol 2013, 58:309-314.
3. Roussos A., Goritsas C., Pappas T., Spanaki M., Papadaki P., Ferti A. Prevalence of hepatitis B and C markers among refugees in Athens. World J Gastroenterol 2003, 9:993-995.
4. Durro V., Koraqi A., Saliasi S. Trends in the prevalence of transfusion-transmissible infections among blood donors in Albania. Clin Lab 2010, 56:591-595.
5. Kondili L.A., Cuko L., Chionne P., Candido A., Madonna E., Dentico P., et al. Hepatitis B, C and delta virus infections in Albanian patients with chronic liver disease: evaluation of possible changes during the last 10 years. Eur J Gastroenterol Hepatol 2010, 22:167-171.
6. Stamouli M., Panagiotou I., Kairis D., Michopoulou A., Skliris A., Totos G. Genotype distribution in chronic hepatitis C patients in Greece. Clin Lab 2012, 58:173-176.
7. Katsoulidou A., Sypsa V., Tassopoulos N.C., Boletis J., Karafoulidou A., Ketikoglou I., et al. Molecular epidemiology of hepatitis C virus (HCV) in Greece: temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates. J Viral Hepat 2006, 13:19-27.
8. Svirtlih N., Delic D., Simonovic J., Jevtovic D., Dokic L., Gvozdenovic E., et al. Hepatitis C virus genotypes in Serbia and Montenegro: the prevalence and clinical significance. World J Gastroenterol 2007, 13:355-360.
9. Seme K., Vrhovac M., Mocilnik T., Maticic M., Lesnicar G., Baklan Z., et al. Hepatitis C virus genotypes in 1,504 patients in Slovenia, 1993-2007. J Med Virol 2009, 81:634-639.
10. Ahmetagic S., Salkic N., Cickusic E., Zerem E., Mott-Divković S., Tihic N., et al. Hepatitis C virus genotypes in chronic hepatitis C patients and in first time blood donors in northeastern Bosnia and Herzegovina. Bosn J Basic Med Sci 2009, 9:278-282.
11. Welsch C., Schweizer S., Shimakami T., Domingues F.S., Kim S., Lemon S.M., et al. Ketoamide resistance and hepatitis C virus fitness in val55 variants of the NS3 serine protease. Antimicrob Agents Chemother 2012, 56:1907-1915.